Anek Lines SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Anek Lines SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8873
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ギリシャ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Anek Lines SA – Strategy, SWOT and Corporate Finance Report
Summary

Anek Lines SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

ANEK Lines S.A. (ANEK) is a transportation services provider. The company’s portfolio of services includes passenger transportation, shipping services, ship management and technical management services. It also provides transportation services for vehicles, transportation of cargo and onboard shop. The ships are certified by the International Safety Management Code. The company’s on-board activities include operating bars, casinos, swimming pool, restaurants and stores. It is also involved in production, distribution and trade of bottled water, vessel agency service, plastic bottles and packaging products. It operates in Ancona, Venice, Adriatic Sea, Crete, Chania, Dodecanese, Cyclades, Ionian Sea and Northeast Aegean routes. ANEK is headquartered in Chania Crete, Greece.

Scope

- Detailed information on Anek Lines SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Anek Lines SA in the form of a SWOT analysis
- An in-depth view of the business model of Anek Lines SA including a breakdown and examination of key business segments
- Intelligence on Anek Lines SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Anek Lines SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Anek Lines SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Anek Lines SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Anek Lines SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Anek Lines SA: Company Overview 6
Anek Lines SA: Overview and Key Facts 6
Anek Lines SA: Overview 6
Anek Lines SA: Key Facts 6
Anek Lines SA: Key Employees 8
Anek Lines SA: Key Employee Biographies 9
Anek Lines SA: Major Products and Services 10
Anek Lines SA: Company History 11
Anek Lines SA: Locations and Subsidiaries 12
Anek Lines SA: Key Competitors 13
Anek Lines SA: Company Analysis 14
Anek Lines SA: Business Description 14
Anek Lines SA: SWOT Analysis 15
Anek Lines SA: SWOT Overview 15
Anek Lines SA: Strengths 15
Anek Lines SA: Weaknesses 16
Anek Lines SA: Opportunities 16
Anek Lines SA: Threats 17
Anek Lines SA: Recent Developments 19
Anek Lines SA: News and Events Summary 19
Anek Lines SA: Financial Performance 19
Anek Lines SA: Regulatory and Legal Events 19
Appendix 21
Contact Us 21
Methodology 21
About MarketLine 22

List of Tables
Table 1: Anek Lines SA: Key Facts
Table 2: Anek Lines SA: Key Employees
Table 3: Anek Lines SA: Company History
Table 4: Anek Lines SA: Locations and Subsidiaries
Table 5: Anek Lines SA: Key Competitors
Table 6: Anek Lines SA: News and Events Summary
Table 7: Anek Lines SA: Financial Performance
Table 8: Anek Lines SA: Regulatory and Legal Events



★海外企業調査レポート[Anek Lines SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Icelandair Group:企業の戦略・SWOT・財務情報
    Icelandair Group - Strategy, SWOT and Corporate Finance Report Summary Icelandair Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Telecom Plus plc (TEP)-エネルギー分野:企業M&A・提携分析
    Summary Telecom Plus plc (Telecom Plus), trading as The Utility Warehouse, is a provider of utility services. The company provides diversified utility services, including fixed and mobile telephony, gas, electricity, cashback card services and broadband services. It provides benefit of single monthl …
  • Risco Energy Investments Pte Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Risco Energy Investments Pte Ltd (Risco Energy Investments) is an energy investment company that acquires, operates, runs, deals, manages, funds and commercialize oil and gas assets. The company undertakes hydrocarbon exploration, production, development, power generation and gas commerciali …
  • Empresaria Group plc (EMR):企業の財務・戦略的SWOT分析
    Empresaria Group plc (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • TVA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • Verona Pharma Plc (VRP):医療機器:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Equipos Nucleares SA:企業の戦略的SWOT分析
    Equipos Nucleares SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Latvenergo AS:企業の戦略的SWOT分析
    Latvenergo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Bunzl plc:企業の戦略・SWOT・財務分析
    Bunzl plc - Strategy, SWOT and Corporate Finance Report Summary Bunzl plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Arsenal Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Arsenal Medical Inc (Arsenal) is a medical technology company that develops polymer based foams and fibers. The company’s products comprise foam system for acute hemorrhage and DARPA collaboration products. Its foam system is an in-situ foaming foams, which is designed for the control of sev …
  • Option NV (OPTI):企業の財務・戦略的SWOT分析
    Option NV (OPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • McDermott International, Inc.:企業の戦略・SWOT・財務情報
    McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report Summary McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Visser & Smit Hanab BV:企業の戦略的SWOT分析
    Visser & Smit Hanab BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • JX Nippon Oil & Energy Corporation-石油・ガス分野:企業M&A・提携分析
    Summary JX Nippon Oil & Energy Corporation (JXNOE) is a downstream refining company. The company refines and markets petroleum and petrochemical products. Its products include petrochemicals, lubricants, optical films, greases, fluids, engine oils, composites, Panaferd-AX, Tow PREPREG, sheet pallet …
  • Zhejiang Xianju Pharmaceutical Co Ltd (002332):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Xianju Pharmaceutical Co Ltd (Zhejiang Xianju Pharmaceutical) is a contract manufacturer of API and formulations. The company offers products such as ingredients, active pharmaceutical ingredients, steroids and hormones, pharmaceutical products, and finished formulations, among othe …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sysmex Corp (6869):製薬・医療:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Phoenix Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Abreos Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆